Revolutionary cancer therapy launched in Britain for the first time: what is the essence of treatment
A revolutionary treatment known as mRNA therapy has been launched at the Hammersmith Hospital in London to treat patients with cancer. It is based on the use of genetic material that transmits common tumor markers to the patient's immune system.
This is stated on the website of Imperial College London. Dr. David Pinato said that the purpose of the new method is to help the immune system recognize and fight cancer cells that use these markers.
"New mRNA-based cancer immunotherapies open the way to engaging the patient's own immune system in the fight against cancer," he said.
According to the scientist, the study is still at an early stage and may take years to become available to patients. However, as Pinato noted, it lays an important foundation that could help develop less toxic and more precise cancer treatments.
"We desperately need them to turn the tide in the fight against cancer," the doctor said.
The study is called Mobilize. In the process, scientists are trying to find out whether this type of mRNA therapy is safe and well tolerated by patients with lung or skin cancer, as well as whether it can shrink tumors.
It is expected that the scenarios for this treatment will vary: in some cases, it will be used alone, in others - in combination with the existing anti-cancer drug pembrolizumab.
The researchers hope this therapy could lead to a new treatment for hard-to-treat cancers if it is proven to be safe and effective.
As a reminder, the well-known anti-cancer drug pembrolizumab (Keytruda), which is used to treat about 19 types of cancer, has received another indication for the treatment of cancer. The US Food and Drug Administration (FDA) has approved the drug for the treatment of advanced cervical cancer. Experts recommend using the PD-1 inhibitor on the first day before chemotherapy.
As reported by OBOZ.UA:
- Medical Procurement of Ukraine (MPU) has signed an agreement for the purchase of 15 innovative Elekta Harmony linear accelerator systems for radiation therapy of cancer with record savings. We managed to save UAH 482 million, or 47% of the approved budget.
- In 2023, 129,682 Ukrainians received free oncology treatment. The services include diagnostics, treatment, including medications, as well as further rehabilitation and palliative care.